Systemic Erythropoietin Injection in Patients Having Optic Atrophy

Alexandria University

Status and phase: Completed; Phase 2; Phase 1

Conditions: Optic Atrophy

Treatments: Drug: Systemic erythropoietin injection

Study type: Interventional

Funder types: Other

Identifiers

NCT04680143

0304845

Details and patient eligibility

About

The purpose of this treatment trial is to study the effect of systemic erythropoietin in patients having optic atrophy.

Full description

The purpose of this treatment trial is to study the effect of systemic erythropoietin in patients having optic atrophy. The intervention is systemic erythropoietin injections (eprax 10000 IU subcutaneous twice daily for three days).

Follow up after one month and three months by recording visual acuity and electro physiological studies.

Enrollment: 10 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Post papilledemic optic atrophy patients

Exclusion criteria

• Refuse to give an informed consent

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

10 participants in 1 patient group

Systemic erythropoietin injections

Experimental group

Description:

The study included 10 patients diagnosed as post papilledemic optic atrophy

Treatment:

Drug: Systemic erythropoietin injection